Literature DB >> 6956889

Extracts of chronic lymphocytic leukemia lymphocytes have a high level of DNA repair activity fo O6-methylguanine.

E A Waldstein, E H Cao, M E Miller, E P Cronkite, R B Setlow.   

Abstract

Extracts of peripheral lymphocytes from six individuals with chronic lymphocytic leukemia (CLL) were assayed for the ability to remove O6-methylguanine (O6MeGua) from exogenous DNA. The O6MeGua-removing activity in CLL lymphocytes, predominantly B cells, was approximately 7-fold higher than in B lymphocytes of normal individuals and about 2-fold higher than in the unstimulated T type cells of normal persons. The activity measured in extracts of lymphocytes from three blood relatives was in the upper range of the normal distribution. Over 80% of the removal of O6MeGua was accomplished by the transfer of the methyl group to cysteine moieties of acceptor proteins in a stoichiometric reaction. If one assumes one acceptor group per acceptor protein, the calculated number of acceptor molecules per CLL lymphocyte falls between 91,000 and 220,000. Thus CLL lymphocytes do not show lower O6MeGua-removing activity, in contrast to many tumor cell strains or transformed cell lines, which are reported to have a deficient methyl excision repair phenotype (Mer-). Instead, the CLL lymphocytes act as if they have a super-Mer+ phenotype.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6956889      PMCID: PMC346763          DOI: 10.1073/pnas.79.15.4786

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  Adaptive response to alkylating agents involves alteration in situ of O6-methylguanine residues in DNA.

Authors:  P Karran; T Lindahl; B Griffin
Journal:  Nature       Date:  1979-07-05       Impact factor: 49.962

3.  Ultraviolet-induced DNA-repair synthesis in lymphocytes from patients with chronic lymphatic leukemia.

Authors:  U Ringborg; B Lambert
Journal:  Cancer Lett       Date:  1977-07       Impact factor: 8.679

Review 4.  N-nitroso alkylating agents: formation and persistence of alkyl derivatives in mammalian nucleic acids as contributing factors in carcinogenesis.

Authors:  B Singer
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

5.  A new pathway for DNA repair in Escherichia coli.

Authors:  L Samson; J Cairns
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

6.  DNA repair in human leukaemic lymphocytes.

Authors:  A T Huang; W B Kremer; J Laszlo; R B Setlow
Journal:  Nat New Biol       Date:  1972-11-22

7.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

8.  Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains.

Authors:  R S Day; C H Ziolkowski; D A Scudiero; S A Meyer; A S Lubiniecki; A J Girardi; S M Galloway; G D Bynum
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

9.  Increased excision of O6-methylguanine from rat liver DNA after chronic administration of dimethylnitrosamine.

Authors:  R Montesano; H Brésil; G P Margison
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

10.  Repair of alkylated DNA in Escherichia coli. Methyl group transfer from O6-methylguanine to a protein cysteine residue.

Authors:  M Olsson; T Lindahl
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

View more
  6 in total

1.  Established cell lines from nonmammalian vertebrates: models for DNA repair studies.

Authors:  E Grist; A D Woodhead; C Carlson
Journal:  In Vitro Cell Dev Biol       Date:  1986-11

Review 2.  Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.

Authors:  P Calsou; B Salles
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Macromolecular DNA-damage in murine and human leukemic and lymphoid cells after in vitro exposure to ASTA Z 7557 (INN mafosfamide).

Authors:  R Osieka; R Pannenbäcker; C G Schmidt
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

4.  6-Methylguanine and 6-methylguanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line but not in other xeroderma pigmentosum and normal human fibroblast strains after treatment with 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea.

Authors:  H W Thielmann; L Edler; N Müller; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Suicide inactivation of the E. coli O6-methylguanine-DNA methyltransferase.

Authors:  T Lindahl; B Demple; P Robins
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

6.  Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.

Authors:  J M Lunn; A L Harris
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.